Maximising the commercial impact of (meta-)genomics via bespoke HMM and big data tools
Lead Participant:
Prozomix Limited
Abstract
This project aims to develop specialised cloud computing software at Newcastle University designed specifically
for big data applications in the area of bioinformatics. The new software will enable scientists at Prozomix
Limited to develop very large panels of biological catalysts (enzyme products) for various fields of application,
but principally the production of active pharmaceutical ingredients (APIs) by synthetic chemists. Such Green-
Chemistry industrial processes are in great demand as they offer the ability to produce such high value
chemicals with significantly less impact on the environment, such as from heavy metals, solvent and other
processing waste generated by traditional chemical processes. As a result such bioprocesses can also reduce
the cost of production of APIs, leading to a positive societal impact through wider availability/increased
effectiveness of drugs. This project will further cement the position of Prozomix Limited as a key supplier of
such innovative biocatalysis enzyme screening products/services, and significantly contribute to the ambition of
the company to become the gold-standard supplier in this rapidly expanding commercial sector.
for big data applications in the area of bioinformatics. The new software will enable scientists at Prozomix
Limited to develop very large panels of biological catalysts (enzyme products) for various fields of application,
but principally the production of active pharmaceutical ingredients (APIs) by synthetic chemists. Such Green-
Chemistry industrial processes are in great demand as they offer the ability to produce such high value
chemicals with significantly less impact on the environment, such as from heavy metals, solvent and other
processing waste generated by traditional chemical processes. As a result such bioprocesses can also reduce
the cost of production of APIs, leading to a positive societal impact through wider availability/increased
effectiveness of drugs. This project will further cement the position of Prozomix Limited as a key supplier of
such innovative biocatalysis enzyme screening products/services, and significantly contribute to the ambition of
the company to become the gold-standard supplier in this rapidly expanding commercial sector.
Lead Participant | Project Cost | Grant Offer |
---|---|---|
Prozomix Limited, Northumberland, United Kingdom | £115,255 | £ 80,679 |
  | ||
Participant |
||
Newcastle University, United Kingdom | £28,073 | £ 28,073 |
People |
ORCID iD |
Darren Cook (Project Manager) |